V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310005087 | 310002322 | null | 59.2 | null | null | 2016-02-29 | RCEOP | N | null | 310025608 | MITOMYCIN |
| 310005088 | 310002323 | 1.62 | 62.45 | Palliative (P) | 2013-11-18 | 2013-11-18 | ICON8B TRIAL | 2 | N | 310025617 | BEVACIZUMAB |
| 310005089 | 310002324 | null | 92 | Not known (9) | null | 2016-08-31 | BEAM + FLUDARABINE | 02 | null | 310025626 | PCV |
| 310005090 | 310006965 | 1.64 | 73.4 | Palliative (P) | null | 2017-01-17 | SCOPE 1 TRIAL | 02 | N | 310025627 | UKALL 2011 |
| 310005091 | 310002325 | 1.71 | 84.5 | Curative (C) | 2017-11-12 | 2017-11-23 | Cytarabine HD + Methotrexate HD | 02 | N | 310025660 | CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 310005092 | 310002326 | null | 67.8 | Palliative (P) | 2014-10-09 | 2014-11-13 | CARBOPLATIN + RT | N | N | 310025661 | CARBOPLATIN + VINORELBINE |
| 310005093 | 310002327 | null | 60 | Palliative (P) | 2016-02-26 | 2016-03-09 | SelPac Trial | 02 | N | 310025665 | ICE-R |
| 310005094 | 310006966 | 1.63 | 44.6 | Palliative (P) | 2013-08-01 | 2013-08-03 | MELPHALAN | N | N | 310025668 | MELPHALAN |
| 310005095 | 310006966 | 1.78 | 71.4 | Palliative (P) | 2017-11-26 | 2017-11-29 | LENALIDOMIDE | N | N | 310025668 | CHLORAMBUCIL |
| 310005096 | 310002328 | 1.85 | 78.3 | Palliative (P) | 2015-10-02 | 2015-11-04 | DABRAFENIB + TRAMETINIB | N | N | 310025674 | CAPECITABINE + STREPTOZOCIN |
| 310005097 | 310002329 | 1.61 | null | Neo-adjuvant (N) | 2014-02-05 | 2014-02-07 | SelPac Trial | 02 | N | 310025680 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005098 | 310002330 | 1.68 | 104.3 | Neo-adjuvant (N) | 2013-07-26 | 2013-08-02 | R GCVP | null | N | 310025683 | CARBOPLATIN + LIPOSOMAL DOX |
| 310005099 | 310002330 | null | 70.3 | Disease modification (D) | 2015-06-14 | 2015-06-17 | Cyclophosphamide High Dose | 02 | N | 310025683 | IVE + METHOTREXATE |
| 310005100 | 310002331 | 1.83 | null | Palliative (P) | 2013-08-14 | 2013-08-16 | Cetuximab + Radiotherapy Load | 02 | N | 310025687 | CAPECITABINE + STREPTOZOCIN |
| 310005101 | 310002332 | 1.75 | 91 | Palliative (P) | 2016-05-19 | 2016-05-20 | Cyclophosphamide Fludarabine (Oral) | N | N | 310025693 | PAZOPANIB |
| 310005102 | 310002332 | 1.71 | 60.1 | Palliative (P) | 2014-02-27 | 2014-02-28 | IVE | N | N | 310025693 | GDP |
| 310005103 | 310002332 | 1.65 | 108 | null | 2013-11-19 | 2013-11-19 | EC | 02 | null | 310025693 | ECHELON-2 TRIAL |
| 310005104 | 310002333 | null | 90.66 | Curative (C) | 2018-01-20 | 2018-01-29 | Cyclophosphamide High Dose | 02 | N | 310025703 | CETUXIMAB + RT |
| 310005105 | 310006969 | 1.68 | 61.1 | null | 2015-07-21 | 2015-08-06 | FEC 100 + DOCETAXEL | N | N | 310025710 | CARBOPLATIN + PEMETREXED |
| 310005106 | 310006969 | 1.77 | 109 | Palliative (P) | 2017-03-22 | 2017-03-23 | Methotrexate intrathecal | 01 | N | 310025710 | R-EPOCH |
| 310005107 | 310006969 | 1.6 | 0 | Palliative (P) | 2014-01-26 | 2014-01-27 | Etoposide oral | N | N | 310025710 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 310005108 | 310011097 | 1.71 | 82.3 | Neo-adjuvant (N) | 2014-09-19 | 2014-09-26 | RPACE-BOM | N | N | 310025719 | CVP |
| 310005109 | 310011097 | 1.68 | 104.3 | Palliative (P) | 2017-06-01 | 2017-08-25 | CYCLOPHOSPHAMIDE | N | N | 310025719 | FEC + DOCETAXEL |
| 310005110 | 310011097 | 1.62 | 67.6 | Palliative (P) | 2014-04-22 | 2013-03-05 | Sunitinib | N | N | 310025719 | FEC + DOCETAXEL |
| 310005113 | 310002334 | 1.83 | 71.7 | Neo-adjuvant (N) | 2017-06-07 | 2017-06-21 | Ifosfamide | 2 | N | 310025743 | IVE |
| 310005114 | 310002335 | 1.68 | null | Disease modification (D) | 2013-07-21 | 2013-07-21 | Carboplatin + Docetaxel | N | N | 310025750 | DOXORUBICIN + IFOSFAMIDE |
| 310005115 | 310002336 | 1.47 | 0 | Palliative (P) | 2016-02-08 | 2016-03-08 | Carbo F | Y | N | 310025753 | MPV |
| 310005116 | 310002336 | null | 71.9 | Palliative (P) | 2015-03-03 | 2015-03-03 | Cisplatin + Dacarbazine | 02 | N | 310025753 | CVP R |
| 310005117 | 310002337 | 1.55 | 64.8 | null | 2017-07-03 | 2017-07-10 | R GCVP | N | null | 310000024 | DABRAFENIB |
| 310005118 | 310002338 | 1.75 | 89.7 | Neo-adjuvant (N) | 2018-08-27 | 2018-08-27 | Pazopanib | N | N | 310000036 | GDP |
| 310005119 | 310002339 | 1.89 | 68 | Neo-adjuvant (N) | 2018-03-03 | 2017-11-11 | IVE | N | N | 310000048 | DABRAFENIB |
| 310005120 | 310002339 | 1.77 | null | Palliative (P) | 2014-03-29 | 2014-04-02 | ECF | N | null | 310000048 | BEVACIZUMAB + IRINOTECAN + MDG |
| 310005121 | 310002340 | 1.7 | 83.5 | Palliative (P) | 2017-11-19 | 2017-11-19 | Cyclophosphamide High Dose | N | N | 310000067 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 310005122 | 310002341 | 1.65 | 52 | Palliative (P) | 2015-07-21 | 2015-07-24 | Capecitabine + Mitomycin | 2 | N | 310000091 | SUNITINIB |
| 310005123 | 310002341 | null | null | Palliative (P) | 2017-04-01 | 2017-04-14 | Enzalutamide | N | null | 310000091 | ECF |
| 310005124 | 310002341 | 0 | 119.2 | Palliative (P) | 2016-04-22 | 2016-05-06 | Pemetrexed | 02 | N | 310000091 | CAPECITABINE + STREPTOZOCIN |
| 310005125 | 310002342 | 1.6 | 81.1 | Curative (C) | 2015-06-23 | 2015-07-09 | Bevacizumab 15mg/kg | N | N | 310000155 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 310005126 | 310006973 | 1.71 | null | Palliative (P) | 2014-03-22 | 2014-04-05 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 310000186 | EURO-EWING |
| 310005127 | 310002343 | 1.63 | 48.6 | Curative (C) | 2015-06-24 | 2015-06-24 | IVE | N | null | 310000191 | DHAP |
| 310005128 | 310002344 | null | null | null | 2016-04-16 | 2016-10-01 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | N | 310000225 | CETUXIMAB |
| 310005129 | 310002344 | 1.61 | 52.9 | Palliative (P) | 2015-01-12 | 2015-01-16 | Temozolomide 200mg/m2 | N | N | 310000225 | ICON8B TRIAL |
| 310005130 | 310002344 | 1.61 | 63.7 | Palliative (P) | 2017-05-02 | 2017-05-02 | Capecitabine + Cisplatin + RT | 2 | N | 310000225 | PAZOPANIB |
| 310005131 | 310002344 | 1.82 | 62 | Adjuvant (A) | 2015-07-02 | 2015-07-02 | RCEOP | N | N | 310000225 | PEG INTERFERON |
| 310005132 | 310002345 | null | 61.6 | Palliative (P) | 2018-06-15 | 2018-06-16 | Cisplatin + Pemetrexed | N | null | 310000351 | GEMCITABINE + NAB-PACLITAXEL |
| 310005133 | 310002346 | 1.69 | 0 | Palliative (P) | 2016-04-08 | 2017-01-18 | BEAM | 02 | N | 310000362 | BEAM |
| 310005134 | 310002347 | 1.48 | 59 | Palliative (P) | 2016-09-29 | 2016-10-29 | Alemtuzumab | N | N | 310000433 | MELPHALAN |
| 310005135 | 310006975 | null | 72 | Palliative (P) | 2016-11-24 | 2016-12-14 | Gemcitabine + Capecitabine | N | N | 310000469 | EDP |
| 310005136 | 310006975 | 1.74 | 50.5 | null | 2017-01-23 | 2017-02-21 | Carbo F | N | N | 310000469 | BLEOMYCIN |
| 310005137 | 310006975 | null | 72.4 | Palliative (P) | 2018-07-30 | 2018-07-31 | TRASTUZUMAB EMTANSINE | 02 | N | 310000469 | SUNITINIB |
| 310005138 | 310002348 | 1.86 | 83 | Palliative (P) | null | 2013-04-27 | Sunitinib | 02 | N | 310000552 | SELPAC TRIAL |